(Q46486537)

English

Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes

scientific article published on 12 May 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15889234

Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15889234

type 2 diabetes

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Markolf Hanefeld

7

object named as

M Hanefeld

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

4

object named as

D R Matthews

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15889234

author name string

B Charbonnel

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15889234

G Schernthaner

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15889234

P Brunetti

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15889234

R Urquhart

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15889234

M H Tan

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15889234

publication date

12 May 2005

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15889234

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15889234

48

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15889234

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15889234

1093-1104

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15889234

https://scigraph.springernature.com/pub.10.1007/s00125-005-1751-1

0 references

The U.K. Prospective Diabetes Study. A review.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-005-1751-1

21 January 2018

The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

UKPDS 28: a randomized trial of efficacy of early addition of metformin in sulfonylurea-treated type 2 diabetes. U.K. Prospective Diabetes Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of pioglitazone compared with metformin on glycemic control and indicators of insulin sensitivity in recently diagnosed patients with type 2 diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved glycaemic control by addition of glimepiride to metformin monotherapy in type 2 diabetic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lipids, glucose intolerance and vascular disease: the Framingham Study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sulfonylureas in NIDDM.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)).

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low density lipoprotein particle size and coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A retrospective chart review of uncontrolled use of metformin as an add-on therapy in type 2 diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination therapy with pioglitazone plus metformin or sulfonylurea in patients with Type 2 diabetes: influence of prior antidiabetic drug regimen

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prospective pioglitazone clinical trial in macrovascular events (PROactive): can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

LDL-cholesterol, HDL-cholesterol or triglycerides--which is the culprit?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15889234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-005-1751-1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15889234

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15889234

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46486537&oldid=2113625945"